Article ID Journal Published Year Pages File Type
8715923 Journal of Investigative Dermatology 2018 4 Pages PDF
Abstract
Pachyonychia congenita is an incurable and often debilitating genodermatosis. Topical application of the antioxidative response inducer sulforaphane, however, alleviates disease symptoms in a murine pachyonychia congenita model, forecasting clinical benefits. The Coulombe laboratory now reports sex-dependent differences in sulforaphane responsiveness of pachyonychia congenita mice, thereby dampening treatment expectations but also unveiling novel aspects of sex-specific oxidative stress reactivity in the epidermis.
Related Topics
Health Sciences Medicine and Dentistry Dermatology
Authors
, ,